Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Recent Clinical Trials on Idiopathic Pulmonary Fibrosis | Download Table
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme | Respiratory Research | Full Text
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
Timeline for landmark trials for antifibrotic therapy for idiopathic... | Download Scientific Diagram
Global Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Highlights - 2022
Phase IV IPF Clinical Trials | ILD Collaborative
Ongoing clinical trials in idiopathic pulmonary fibrosis | Download Table
Targeting fibrosis: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Enrollment now complete for Phase 3 trial of pamrevlumab in IPF | Results from FibroGen study ZEPHYRUS-2 expected in mid-2024 | Pulmonary Fibrosis News
Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions: Molecular Therapy - Methods & Clinical Development
Clinical trials in lung fibrosis - Lung Foundation Australia
Clinical Trials | Pulmonary Fibrosis Foundation
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Top 10 IPF Clinical Trials [2023 Studies] | Power](https://pwr-og-img.withpower.com/IPF%20research%20studies%20recruiting%20patients%20in%202023%20need%20your%20help.%20Receive%20premium%20care%20&%20cutting%20edge%20treatments%20by%20enrolling%20in%20idiopathic%20pulmonary%20fibrosis%20clinical%20trials%20today..png?md=1 "Top 10 IPF Clinical Trials [2023 Studies] | Power")
Top 10 IPF Clinical Trials [2023 Studies] | Power
Idiopathic pulmonary fibrosis - Wikipedia
The therapy of idiopathic pulmonary fibrosis: what is next? | European Respiratory Society
Idiopathic Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2, 2020
Clinical Trials for Pulmonary Fibrosis: How Can Participation Be Improved? - Xtalks
Clinical Trials | Pulmonary Fibrosis Foundation
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial - The Lancet Respiratory Medicine
Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
